Buy Dr. Lal Pathlabs Limited and Thyrocare Technologies Limited

buy

Buy Dr. Lal Pathlabs Limited:

Dr. Lal Pathlabs Limited

Dr. Lal Pathlabs Ltd has officially announced a consolidated sales of Rs. 465.90 Cr for the third quarter finished on 31-12-2020, which is 4.74% up from its previous quarter sales of Rs. 444.80 Cr and 36.35% up from its previous year same quarter sales of Rs. 341.70 Cr. The company has reported a net profit after tax of Rs. 95.90 Cr in the previous quarter.

Outlook:

Dr. Lal Pathlabs Ltd: Experts suggested buy call at current market price: Rs. 3,137.00 with a target price: Rs. 3,200; Stoploss: Rs. 3,120.

Buy Thyrocare Technologies Limited:

Thyrocare Technologies Ltd has officially announced a consolidated sales of Rs. 140.85 Cr for the third quarter finished on 31-12-2020, which is -10.99% down from its previous quarter sales of Rs. 158.24 Cr and 32.08% up from its previous year same quarter sales of Rs. 106.64 Cr. The company has reported net profit after tax of Rs. 32.33 Cr in the previous quarter.

Outlook:

Thyrocare Technologies Ltd: Experts suggested buy call at current market price: Rs. 1,042.95 with a target price: Rs. 1,075; Stoploss: Rs. 1,030.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Leave a Reply

Your email address will not be published. Required fields are marked *